Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561157 · ClinicalTrials.gov registry record
Longitudinal Study of the Porphyrias
A clinical trial of Acute Porphyrias and Cutaneous Porphyrias, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 15
- Study locations
NCT01561157: Recruiting study of Acute Porphyrias and Cutaneous Porphyrias, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01561157 is a study of Acute Porphyrias and Cutaneous Porphyrias that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,500 participants. The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01561157, a study of Acute Porphyrias and Cutaneous Porphyrias, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Primary Outcome
To develop disease severity scores to describe the combined frequency and severity of disease manifestations, utilizing linear mixed effects models \& stratification by age of onset.
Conditions Studied
Study Locations (15)
California
- University of California, Los Angeles - Los Angeles
- University of California, San Francisco - San Francisco
North Carolina
- Carolinas Medical Center and HealthCare System - Charlotte
- Wake Forest University Health Sciences - Winston-Salem
Alabama
- University of Alabama, Birmingham - Birmingham
Florida
- University of Miami - Miami
Illinois
- University of Illinois at Chicago - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2010-11-01 |
| Est. Completion | 2030-06-30 |
What NCT01561157 shows while recruiting
NCT01561157 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Acute Porphyrias appearing as the primary indexed condition, and to 0 interventions.
NCT01561157 lists 15 locations in 13 states (California, North Carolina, Alabama).
Frequently Asked Questions
What is clinical trial NCT01561157 about?
NCT01561157 is a clinical study titled "Longitudinal Study of the Porphyrias". The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
What is the current status of trial NCT01561157?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2010-11-01. Estimated completion is 2030-06-30.
What conditions does trial NCT01561157 study?
This clinical trial studies the following conditions: Acute Porphyrias, Cutaneous Porphyrias.
Who is sponsoring clinical trial NCT01561157?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01561157 being conducted?
This trial has 15 study locations across Alabama, California, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI